Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

El Mustapha Bahassi

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Nature Communications|July 21, 2011
Functional and molecular interactions between ERK and CHK2 in diffuse large B-cell lymphomaBojie Dai, X Frank Zhao, Krystyna Mazan-Mamczarz, et al.
Cell Division|February 12, 2011
A human cancer-predisposing polymorphism in Cdc25A is embryonic lethal in the mouse and promotes ASK-1 mediated apoptosisEl Mustapha Bahassi, Moying Yin, Susan B Robbins, et al.
Mutation Research|December 19, 2006
The breast cancer susceptibility allele CHEK2*1100delC promotes genomic instability in a knock-in mouse modelEl Mustapha Bahassi, C Gail Penner, Susan B Robbins, et al.
Mutagenesis|August 9, 2014
Whole genome sequencing of glioblastoma multiforme identifies multiple structural variations involved in EGFR activationJohn M Furgason, Wenge Li, Brandon Milholland, et al.
European Journal of Cancer (Oxford, England : 1990)|April 13, 2013
A patient-derived somatic mutation in the epidermal growth factor receptor ligand-binding domain confers increased sensitivity to cetuximab in head and neck cancerEl Mustapha Bahassi, Ya-Qin Li, Trisha M Wise-Draper, et al.
The Lancet. Diabetes & Endocrinology|January 27, 2025
Lerodalcibep and evolocumab for the treatment of homozygous familial hypercholesterolaemia with PCSK9 inhibition (LIBerate-HoFH): a phase 3, randomised, open-label, crossover, non-inferiority trialFrederick J Raal, Vimal Mehta, Meral Kayikcioglu, et al.
Cancer Letters|May 4, 2010
Chk2*1100delC Acts in synergy with the Ron receptor tyrosine kinase to accelerate mammary tumorigenesis in miceSara E Meyer, Belinda E Peace, El Mustapha Bahassi, et al.
Viruses|January 9, 2021
Patient-Derived Organotypic Epithelial Rafts Model Phenotypes in Juvenile-Onset Recurrent Respiratory PapillomatosisMary C Bedard, Marion G Brusadelli, Adrean Carlile, et al.
Cancer Cell|May 12, 2016
Olig2-Dependent Reciprocal Shift in PDGF and EGF Receptor Signaling Regulates Tumor Phenotype and Mitotic Growth in Malignant GliomaFanghui Lu, Ying Chen, Chuntao Zhao, et al.
Clinical Neuropathology|December 19, 2014
Brain Tumor Epidemiology - A Hub within Multidisciplinary Neuro-oncology. Report on the 15th Brain Tumor Epidemiology Consortium (BTEC) Annual Meeting, Vienna, 2014Adelheid Woehrer, Ching C Lau, Daniela Prayer, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Nature Communications|July 21, 2011
Functional and molecular interactions between ERK and CHK2 in diffuse large B-cell lymphomaBojie Dai, X Frank Zhao, Krystyna Mazan-Mamczarz, et al.
Cell Division|February 12, 2011
A human cancer-predisposing polymorphism in Cdc25A is embryonic lethal in the mouse and promotes ASK-1 mediated apoptosisEl Mustapha Bahassi, Moying Yin, Susan B Robbins, et al.
Mutation Research|December 19, 2006
The breast cancer susceptibility allele CHEK2*1100delC promotes genomic instability in a knock-in mouse modelEl Mustapha Bahassi, C Gail Penner, Susan B Robbins, et al.
Mutagenesis|August 9, 2014
Whole genome sequencing of glioblastoma multiforme identifies multiple structural variations involved in EGFR activationJohn M Furgason, Wenge Li, Brandon Milholland, et al.
European Journal of Cancer (Oxford, England : 1990)|April 13, 2013
A patient-derived somatic mutation in the epidermal growth factor receptor ligand-binding domain confers increased sensitivity to cetuximab in head and neck cancerEl Mustapha Bahassi, Ya-Qin Li, Trisha M Wise-Draper, et al.
The Lancet. Diabetes & Endocrinology|January 27, 2025
Lerodalcibep and evolocumab for the treatment of homozygous familial hypercholesterolaemia with PCSK9 inhibition (LIBerate-HoFH): a phase 3, randomised, open-label, crossover, non-inferiority trialFrederick J Raal, Vimal Mehta, Meral Kayikcioglu, et al.
Cancer Letters|May 4, 2010
Chk2*1100delC Acts in synergy with the Ron receptor tyrosine kinase to accelerate mammary tumorigenesis in miceSara E Meyer, Belinda E Peace, El Mustapha Bahassi, et al.
Viruses|January 9, 2021
Patient-Derived Organotypic Epithelial Rafts Model Phenotypes in Juvenile-Onset Recurrent Respiratory PapillomatosisMary C Bedard, Marion G Brusadelli, Adrean Carlile, et al.
Cancer Cell|May 12, 2016
Olig2-Dependent Reciprocal Shift in PDGF and EGF Receptor Signaling Regulates Tumor Phenotype and Mitotic Growth in Malignant GliomaFanghui Lu, Ying Chen, Chuntao Zhao, et al.
Clinical Neuropathology|December 19, 2014
Brain Tumor Epidemiology - A Hub within Multidisciplinary Neuro-oncology. Report on the 15th Brain Tumor Epidemiology Consortium (BTEC) Annual Meeting, Vienna, 2014Adelheid Woehrer, Ching C Lau, Daniela Prayer, et al.
Pageof 3